The disappointing results of hydroxychloroquine for covid-19 patients
“Study finds no benefit, higher death rate in patients taking hydroxychloroquine for Covid-19” (CNN) is discouraging. We’re apparently not on track to have a better drug treatment for coronavirus infections any time soon, thus potentially casting doubt on the value of “flatten the curve”. If we should be unfortunate enough to get seriously ill from COVID-19, we’ll get the same drugs next month that we would have gotten last month.
(Maybe flattening the curve is still worthwhile because then everyone can get onto a ventilator if necessary? “Nearly all Covid-19 patients put on ventilators in New York’s largest health system died, study finds” (CNN) says that 88 percent of patients on ventilators died. The true number is probably higher, since a lot of patients suffer so much organ damage that they die after being discharged from the hospital where they were on the ventilator. This number is consistent with what my physician friends had told me and what the Chinese found; see April 2 post.)
Should we abandon hope for hydroxychloroquine? A doctor friend responded to my questions with, essentially, “not on the basis of this VA study”:
- It didn’t fail for indication / mechanism of its action
- It’s a study done at the wrong stage of disease for the drug to work
- So much garbage published
- It works at very early stage of disease to block viral replication
- If you give it to people who are dying in icu from cytokines storm it’s useless
- They didn’t separate the patients
(she had only skimmed the paper, so might be wrong about some details)
Not everyone is upset at the failed outcome of this study. My Facebook feed has been alive with glee that the drug does not help people who are suffering and dying from covid-19. They write posts highlighting Donald Trump’s expressed enthusiasm about the drug back in March and then linking to articles about the VA study. Oddly, these expressions of delight come from the same people who are most vocal in their demands for additional shutdown because suffering and dying from covid-19 must be avoided at all costs. This is consistent with my April 7 post:
As much as I want this whole Covid-19 thing to be over, my biggest fear is that it will abate and the stock market/economy will rebound in time for the November election and Trump will claim credit and be re-elected.
Yet I was still unable to think of any situation in which so many people have been happy about a failed drug trial.
Readers who know more about medicine and pharma: Based on the trials that have been done, do we know whether hydroxychloroquine helps covid-19 patients? Anything else that seems promising for the near-term?
Related:
- Dr. Betty Light explains how to protect yourself and others during the shutdown
- “New data on Gilead’s remdesivir, released by accident, show no benefit for coronavirus patients. Company still sees reason for hope” (STAT, 4/23)
- Bill Gates’s April 23 coronaplague post: “Another class of drugs works by changing how the human body reacts to the virus. Hydroxychloroquine is in this group. The foundation is funding a trial that will give an indication of whether it works on COVID-19 by the end of May. It appears the benefits will be modest at best.” Gates also notes that poor Americans are being destroyed: “The heavy cost of the pandemic for lower-paid and poor people is a special concern for Melinda and me. The disease is disproportionately hurting poorer communities and racial minorities. Likewise, the economic impact of the shutdown is hitting low-income, minority workers the hardest. Policymakers will need to make sure that, as the country opens up, the recovery doesn’t make inequality even worse than it already is.” (Maybe it would help the American poor and dark-skinned that Gates purports to care about if rich people, instead of paying taxes on capital gains from their appreciated stock, funneled the money overseas via a charitable foundation.)









